CD28 Costimulation Promotes the Production of Th2 Cytokines

Journal of Immunology

Volumn 158, Issue 2, 1997, Pages 658-665

  Rulifson, Ingrid C ^a   Sperling, Anne I ^a   Fields, Patrick E ^a   Fitch, Frank W ^a   Bluestone, Jeffrey A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYTOKINE; LYMPHOCYTE ANTIGEN RECEPTOR; MONOCLONAL ANTIBODY;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; DBA MOUSE; DRUG EFFECT; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; SIGNAL TRANSDUCTION; TH2 CELL; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; CYTOKINES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SIGNAL TRANSDUCTION; TH2 CELLS;

EID: 0031567907     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Lenschow, D. J., Y. Zeng, K. Hathcock, L. A. Zuckerman, G. Freeman, J. R. Thistlethwaite, T. A. Barrett, G. S. Gray, J. Miller, R. I. Modes, and J. A. Bluestone. 1995. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Transplantation 60:1711.
2. Lenschow, D. J., Y. Zeng, J. R. Thistlethwaite, A. Montag. W. Brady, M. G. Gibson, P. S. Linsley. and J. A. Bluestone. 1992. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 257:789.
3. Turka, L. A., P. S. Linsley, H. Lin, W. Brady, J. M. Leiden, R. Wei, M. L. Gibson, X. Zhen, S. Myrdal, D. Gordon, T. Bailey, S. F. Boiling, and C. B. Thompson. 1992. T cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc. Natl. Acad. Sci. USA 89:11102.
4. + T lymphocytes from TCR transgenic mice. J. Immunol. 152:5220.
5. Lenschow, D. J., S. C. Ho, H. Sattar, L. Rhee, G. S. Gray, N., Nabavi, K. C. Herold, and J. A. Bluestone. 1995. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 181:1145.
6. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80:707.
7. Karandikar, N. J., C. L. Vanderlugt, T. L. Walunas, S. D. Miller, and J. A. Bluestone. 1996. CTLA-4: a negative regulator of autoimmune disease. J. Exp. Med. 184:783.
8. Shahinian, A., K. P. Pfeifer, T. M. Lee, K. Kundig, A. Kishihara, Wakeham, K. Kawai, P. S. Ohashi, C. B. Thompson, and T. W. Mak. 1993. Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609.
9. Green, J. M., P. J. Noel, A. I. Sperling, T. L. Walunas, G. S. Gray, J. A. Bluestone, and C. B. Thompson. 1994. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1:501.
10. Murphy, K. M., C. T. Weaver, M. Elish, P. M. Allen, and D. Y. Loh. 1989. Peripheral tolerance to allogeneic class II histocompaubility antigens expressed in transgenic mice: evidence against a clonal deletion mechanism. Proc. Natl. Acad. Sci. USA 86:10034.
11. + T-cell clone. Proc. Natl. Acad. Sci. USA 90:11272.
12. Sha, W. C., C. A. Nelson, R. D. Newberry, D. M. Kranz, J. H. Russell, and D. Y. Loh. 1988. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 336:73.
13. Gross, J. A., E. Callas, and J. P. Allison. 1992. Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 149:380.
14. Walunas, T. L., A. I. Sperling, R. Khattri, C. B. Thompson, and J. A. Bluestone. 1996. CD28 expression is not essential for positive and negative selection of thymocytes or peripheral T ceil tolerance. J. Immunol. 156:1006.
15. Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone, 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Nutl. Acad. Sci. USA 84:1374.
16. Bruce, J., F. W. Symington, T. J. McKeam, and J. Sprent. 1981. A monoclonal antibody discriminating between subsets of T and B cells. J. Immunol. 127:2496.
17. Kappler, J. W., B. Skidmore, J. White, and P. Marrack. 1981, Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas: lack of independent antigen and H-2 recognition. J. Exp. Med 153:1198.
18. Cherwinski, H., K. Schumacher, and T. Mossman, 1987. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th 1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229.
19. Ohara, J., and W. E. Paul. 1985. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 315:333.
20. Sarmiento, M., M. R. Loken, and F. W. Fitch. 1981. Structural differences in cell surface T25 polypeptides from thymocytes and cloned T cells. Hybriduma 1:13.
21. Lucas, P. J., I. Negishi, K. Nakayama, L. E. Fields, and D. Y. Loh. 1995. Naive CD28-deficient T cells can initiate but not sustain an in vitro antigen-specific immune response. J. Immunol. 154:5757.
22. + T cells secreting Th 1 or Th2 cytokines. Immunity 2:271.
23. + T cells into subpopulations with distinct cytokine profiles. J. Immunol. 155:2928.
24. Seder, R. A., R N. Germain, P. S. Linsley, and W. K. Paul. 1994. CD28-mediated costimulation of interleukin 2 (IL-2) production plays a critical role in T cell priming for IL-4 and interferon gamma production. J. Exp. Med. 179:299.
25. Bradding, P., I. H. Feather, P. H. Howarth, R. Muller, J. A. Roberts, K. Britten, J. P. Bews, T. C. Hunt, Y. Okayama, C. H. Heusser, G. R. Bullock, M. K. Church, and S. T. Holgate. 1992. Interleukin 4 is localized to and released by human mast cells. J. Exp. Med. 176:1381.
26. Ferrick, D. A., M. D. Schrenzel, T. Mulvania, B. Hsieh, W. G. Ferlin, and H. Lepper. 1995. Differential production of interferon-γ and interleukin-4 in response to Th1-and Th-2-stimulating pathogens by γδ T cells in vivo. Nature 373:255.
27. - thymocytes with specific lymphokine secretion. Emr. J. Immunol. 23:307.
28. pos™ T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179:1285.
29. Kamogawa, Y., L. A. Minasi, S. R. Carding, K. Bottomly, and R. A. Flavell. 1993. The relationship of IL-4-and IFN-gamma-producing T cells studied by lineage ablation of IL-4-producing cells. Cell 75:985.
30. Corry, D. B., S. L. Reiner, P. S. Linsley, and R. M. Lockslcy. 1994. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J. Immunol. 153:4142.
31. Lu, P., X. Zhou, S. J. Chen, M. Moorman, S. C. Morris, F. D. Finkelman, P. Linsley, J. F. Urban, and W. C. Gause. 1994. CTLA-4 ligands are required to induce an in vivo interleukin 4 response to a gastrointestinal nematode parasite. J. Exp. Med. 180:693.
32. Lenschow, D. J., L. Rhee, B. Patel, K. Herold, E. Fuchs, B. Singh, C. B. Thompson, and J. A. Bluestone. 1996. CD28/B7 regulation of Th1 and Th2 subsets in the development and progression of autoimmune diabetes. Immunity 5:285.